Upper airway resistance syndrome, or UARS, describes sleep-disrupting narrowing of the upper airway that increases breathing effort and can end in brief brain arousals. These events may be clinically important even when the apnea-hypopnea index (AHI) is low and oxygen levels do not fall substantially.
UARS does not have one universally accepted diagnostic cutoff. The current International Classification of Sleep Disorders no longer treats it as a separate disorder. Instead, obstructive events that end in respiratory effort-related arousals, or RERAs, can contribute to a diagnosis of obstructive sleep apnea (OSA). Clinicians and researchers still use the UARS label to emphasize symptomatic airflow limitation and sleep fragmentation that the apnea-hypopnea index may not fully describe 12.
This classification issue is more than semantics. Whether an event is called a hypopnea or a RERA can depend on the scoring rule and signals used. A report that says "normal AHI" therefore does not answer every question about sleep-related breathing.
What UARS means in current practice
During sleep, the throat can narrow without closing completely. Air continues to move, but the shape of the airflow signal may flatten and the muscles that drive breathing may work harder. If the effort ends in a brief shift toward wakefulness, the event may qualify as a RERA if it does not already meet the criteria for an apnea or hypopnea 1.
Many published UARS studies have used a pattern such as:
- symptoms including unrefreshing sleep, sleepiness, or fatigue
- a low AHI
- repeated RERAs, an elevated respiratory disturbance index (RDI), or substantial inspiratory flow limitation
The exact thresholds differ across studies. One study's definition should not be treated as a universal clinical rule. Current OSA criteria can also count RERAs, so a person with this physiology may receive an OSA diagnosis rather than a separate UARS diagnosis 31.
UARS is not reliably defined as "pre-apnea," a milder stage that inevitably becomes OSA, or a midpoint between harmless snoring and OSA. The label also does not determine how impaired a person feels. A low AHI can coexist with substantial sleep fragmentation, while airflow flattening can appear without proving that it is the cause of symptoms.
The numbers on a sleep report
| Measure | What it usually counts | Important limitation |
|---|---|---|
| AHI | Apneas plus hypopneas per hour of measured sleep | The result changes with the hypopnea scoring rule and does not include separately scored RERAs |
| RERA index | RERAs per hour of measured sleep | RERA scoring is not performed or reported uniformly |
| RDI | Apneas, hypopneas, and RERAs per hour of measured sleep under the AASM definition | Some laboratories, devices, and payers use the term differently, so check the report's definition |
| REI | Respiratory events per hour of monitoring or estimated sleep time on a home test | Without direct sleep measurement, recording time can dilute the event rate; most home tests cannot score EEG arousals |
| ODI | Oxygen drops of a specified size per hour | It does not measure airflow limitation, breathing effort, or arousals that occur without a qualifying oxygen drop |
AASM's recommended adult hypopnea rule counts a breathing reduction lasting at least 10 seconds when it is accompanied by either a 3% oxygen drop or an EEG arousal. An alternative rule used by some payers requires a 4% oxygen drop and does not count an arousal alone. The same night can therefore produce different AHI values under different rules 21.
If a report lists AHI, RDI, or RERAs, read the definitions section rather than relying on the label alone. Useful questions include:
- Which hypopnea rule was used?
- Were RERAs scored, and how does this laboratory define RDI?
- Did the test measure actual sleep and EEG arousals?
- Was the recording technically adequate, and did it include enough of the sleep positions and stages relevant to the clinical question?
RERAs, flow limitation, and oxygen
A RERA is a sequence of breaths lasting at least 10 seconds with increasing respiratory effort or flattening of the inspiratory nasal-pressure signal that leads to an arousal from sleep. It must not already qualify as an apnea or hypopnea 1.
Flow limitation is a clue, not a diagnosis by itself. A flattened inspiratory waveform can suggest that airflow is no longer rising normally as breathing effort increases. The signal still has to be interpreted in context. Sensor fit, nasal congestion, mouth breathing, sleep stage, position, associated effort, and whether an EEG arousal follows all matter. A single flattened trace on a screenshot cannot establish UARS.
Oxygen may remain relatively stable when an arousal reopens the airway before a large oxygen drop develops. That is one reason oxygen-only devices can miss arousal-based obstruction. However, there is no universal saturation floor that separates UARS from OSA. Normal overnight oximetry does not rule out either condition, and an oxygen drop below a particular percentage does not automatically change a UARS event into OSA. Apneas, hypopneas, RERAs, oxygen burden, sleep fragmentation, symptoms, and health context need to be considered together 23.
Symptoms can be important but are not specific
People evaluated for UARS commonly report unrefreshing sleep, daytime sleepiness or fatigue, repeated awakenings, insomnia-like symptoms, morning headaches, reduced concentration, or mood changes. Snoring may be present, quiet, or unreported. A retrospective sleep-clinic study found that people meeting one research definition of UARS had substantially worse health-related quality of life than a general population comparison group, but a study like this cannot tell whether any one person's symptoms come from UARS 4.
These symptoms are shared by many conditions. Sleepiness means a tendency to doze or fall asleep, while fatigue is a lack of energy or endurance. A person can have either or both, and the distinction can guide the evaluation.
UARS cannot be identified by appearance. Early reports often emphasized younger people with lower body mass index, but the evidence is limited and referral patterns differ. People of any sex, age, or body size can have clinically important obstructive breathing. A narrow jaw, high-arched palate, nasal obstruction, or another anatomical feature may influence breathing, but a facial profile, dental image, or airway scan cannot confirm or exclude the disorder 1.
How UARS-related breathing is evaluated
A clinician starts with the pattern of symptoms, sleep opportunity, medication and substance use, nasal and breathing complaints, medical history, and signs reported by a bed partner. Questionnaires can help screen for OSA or measure sleepiness, but they cannot make or exclude the diagnosis on their own 5.
In-laboratory polysomnography
Polysomnography records sleep and breathing at the same time. A full study commonly includes:
- EEG and related sensors to identify sleep stages and arousals
- nasal pressure and an oral-nasal thermal sensor to measure airflow
- chest and abdominal belts to estimate breathing effort
- pulse oximetry, heart rhythm, body position, and leg movement channels
These signals let the scorer ask whether a flow-limited sequence ended in an EEG arousal and whether it met the definition of a hypopnea or RERA 1.
Esophageal pressure monitoring, often abbreviated as Pes, uses a thin catheter to measure changes in pressure within the esophagus as a close indicator of respiratory effort. It played an important role in the original description of UARS and can detect progressively more negative pressure before an arousal. It is invasive and is not required in every suspected case. Modern laboratories often infer flow limitation from nasal-pressure shape together with effort belts and EEG, although practices and scoring expertise vary.
Home sleep apnea tests
A technically adequate home sleep apnea test can diagnose OSA in selected adults who have a high pretest likelihood of moderate to severe disease and no complicating condition. It is not a general test for every cause of poor sleep 5.
Most home tests do not record EEG, so they cannot directly identify sleep or score an arousal. Many calculate REI using monitoring time rather than measured sleep time. This can miss or understate events that mainly cause arousal rather than oxygen drops. Some devices estimate sleep or arousals indirectly from peripheral signals, but those estimates are not the same as direct EEG scoring.
When a home test is negative, inconclusive, or technically inadequate and clinical concern persists, AASM guidance recommends in-laboratory polysomnography rather than assuming sleep-related breathing has been ruled out 52.
Consumer trackers and PAP screenshots
Wearables, phone apps, rings, and consumer oxygen monitors can reveal patterns worth discussing with a clinician. They do not record the complete, validated signal set needed to diagnose UARS, score RERAs, or rule out OSA. The AASM advises that consumer sleep technology should not replace validated diagnostic testing 6.
A PAP device's flow graph can also show possible flattening, but it does not record EEG arousals. Device algorithms and displayed event labels vary. A screenshot can help a sleep clinician review treatment, but it cannot establish UARS or define the correct pressure. Do not change prescribed pressure settings solely in response to a consumer score or waveform.
Other problems can look similar or coexist
Unrefreshing sleep, awakenings, sleepiness, fatigue, and morning symptoms do not identify their cause. The evaluation should consider other sleep disorders, sleep opportunity and timing, medicines and substances, and relevant medical or mental health conditions 35.
| Possibility | What may overlap | What helps separate it |
|---|---|---|
| Primary snoring | Upper-airway sound without obvious pauses | A clinical evaluation and, when indicated, testing determine whether obstructive events or daytime impairment are also present |
| Obstructive sleep apnea | Snoring, flow limitation, arousals, sleepiness, fatigue, headaches | Apneas, hypopneas, RERAs, oxygen effects, and the full diagnostic criteria are considered; UARS and OSA are not separated by one oxygen number |
| Chronic insomnia | Difficulty falling asleep, repeated awakenings, unrefreshing sleep, daytime fatigue | Insomnia requires adequate opportunity for sleep and its own symptom pattern; it can remain present even after breathing is treated |
| Insufficient sleep or a circadian mismatch | Sleepiness, fatigue, poor concentration | Sleep timing, work or school demands, and a sleep diary may show too little opportunity or a biological schedule conflict |
| Narcolepsy or another hypersomnolence disorder | Strong sleepiness and unintended sleep episodes | A specialist may investigate REM-related symptoms and persistent sleepiness after adequate sleep and other disorders are addressed |
| Nasal obstruction, asthma, or reflux | Noisy breathing, awakenings, chest or throat symptoms | Daytime and nighttime symptom patterns, examination, and condition-specific testing are needed; none proves UARS on its own |
| Panic symptoms or dysautonomia | Racing heart, sweating, dizziness, abrupt awakenings | These features are not unique to respiratory arousals and require their own clinical assessment |
| Medication, substance, or medical effects | Fragmented sleep, sleepiness, fatigue, headaches | A careful timeline and medical review may identify sedatives, stimulants, alcohol, withdrawal, pain, anemia, thyroid disease, mood disorders, or another contributor |
More than one explanation can be correct. Treating nasal allergies does not exclude OSA. Diagnosing OSA does not mean every awakening is respiratory. Persistent symptoms after adequate treatment should prompt a review of sleep duration, insomnia, movement disorders, medications, mood, pain, and other medical causes rather than an automatic increase in airway pressure.
Treatment is individualized
The aim is not to make a waveform look perfect. It is to reduce clinically meaningful obstructive events and sleep disruption, improve daytime function, and use a treatment the person can sustain. Anatomy, the complete sleep study, symptom burden, preferences, other conditions, and response to prior treatment all matter.
Evidence for treatment specifically labeled UARS is limited. A review found mostly small case series and few controlled trials, with inconsistent definitions across studies 7. Current classification often places RERA-based disease under OSA, so clinicians may also draw on OSA treatment evidence while remaining clear about what has and has not been studied in a UARS population.
Positive airway pressure
Positive airway pressure, or PAP, splints the upper airway open during sleep. Small UARS studies suggest that CPAP can reduce flow limitation, respiratory arousals, and symptoms in some patients, but response and tolerance vary 7.
There is no universal UARS pressure and no rule that one PAP mode is best for everyone. Pressure is selected from the diagnostic findings, titration or device data, symptoms, comfort, leak, and clinician review. Higher pressure is not automatically better. Self-adjusting a prescribed device to suppress every visible flattening can create discomfort, leak, or poorer sleep without proving that the target was clinically important.
Oral appliance therapy
A mandibular advancement device moves the lower jaw forward to enlarge and stabilize the airway. One small randomized trial in people meeting a study definition of UARS found improvements in respiratory measures and some daytime outcomes with long-term mandibular advancement therapy, but it does not establish that an appliance will work for every patient 8.
For OSA, AASM and dental sleep medicine guidance favors a custom, titratable appliance fitted and monitored by a qualified dentist over a noncustom device. Follow-up checks are needed for jaw discomfort, dental movement, bite changes, and adherence, and follow-up sleep testing is suggested to confirm efficacy 9. An over-the-counter mouthguard or tongue device is not an equivalent substitute.
Nasal, positional, and related care
Allergic rhinitis, a deviated septum, enlarged turbinates, or nasal valve problems may add resistance or make PAP harder to tolerate. Treating a documented nasal condition can improve nasal breathing and treatment comfort. It should not be presented as an automatic cure for sleep-related airway collapse.
Positional therapy is most defensible when the sleep study shows that events are meaningfully worse in a particular position. Side sleeping is not a universal UARS treatment. Likewise, weight management may be relevant to a person's overall OSA plan, but UARS is not defined by weight and treatment should not be withheld from a person in a smaller body.
Insomnia, asthma, reflux, pain, anxiety, and other coexisting problems may need their own treatment. General sleep habits can support health, but sleep hygiene alone does not correct documented upper-airway obstruction.
Surgery
Surgery is considered only after identifying a plausible anatomical target and weighing less invasive options, expected benefit, and risk. Procedures can address the nose, tonsils, palate, tongue region, or jaws, but they are not interchangeable.
UARS-specific surgical evidence is sparse. A systematic review and meta-analysis found only a few small, lower-quality studies with varied procedures. Sleepiness improved in pooled results, while objective respiratory measures did not show a consistent significant change 10. Surgery should not be promised as a cure, and symptoms alone should not be used to declare success. Objective follow-up may be needed.
How to judge whether treatment is working
Follow-up should consider several kinds of evidence:
- changes in sleepiness, fatigue, awakenings, sleep quality, and daily function
- adherence, comfort, leak, side effects, and reasons a treatment is not being used
- device or laboratory data relevant to the treatment
- repeat testing when it is needed to confirm efficacy, especially after oral appliance therapy or an anatomical intervention
- other causes when symptoms persist despite adequate control of respiratory events
Less snoring or more energy is encouraging, but neither proves that obstructive events are controlled. Conversely, a low device-reported AHI does not show whether EEG arousals remain because a PAP machine does not measure them.
Scoring and coverage policies can complicate care. AASM's recommended rule recognizes arousal-based hypopneas and its RDI includes RERAs, while some payer policies rely on oxygen-based criteria. If report labels or coverage do not match the clinical explanation, ask the sleep clinic which criteria were used and what documentation or testing is appropriate. Do not alter a diagnosis or treatment on your own to fit a billing label 2.
When to seek care
Arrange a sleep evaluation when unrefreshing sleep, sleepiness, fatigue, repeated awakenings, or breathing concerns persist despite adequate opportunity for sleep. Mention witnessed pauses, choking or gasping, snoring, nasal symptoms, medication changes, and any prior home test. Bring the complete report rather than only the AHI.
Do not drive when you are struggling to stay alert. If sleepiness develops while driving, pull over in a safe place rather than trying to push through it 11.
Sudden or severe trouble breathing while awake, inability to speak normally because of breathlessness, blue lips, or new confusion can be an emergency. Call the local emergency number rather than assuming the problem is UARS 12.
The bottom line
UARS is best understood as a clinically useful description of upper-airway flow limitation, increased effort, and respiratory arousals that may not be obvious from the AHI or oxygen trace alone. Current classification generally places RERA-based disease within OSA, but testing and terminology still vary.
Diagnosis requires the whole clinical picture and appropriately interpreted sleep signals. There is no universal UARS cutoff, oxygen threshold, body type, PAP pressure, or treatment hierarchy. When the findings and symptoms align, PAP, a custom oral appliance, anatomy-specific care, or selected surgery may help. The plan should be individualized and checked by both daytime outcomes and appropriate objective follow-up.
